Tokyo, Aug. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062683) titled 'Study of Safe Use of Clazosentan in Patients with Aneurysmal Subarachnoid Hemorrhage' on Aug. 25.
Study Type:
Observational
Primary Sponsor:
Institute - University of Shizuoka
Condition:
Condition - Subarachnoid hemorrhage
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - To clarify the association between OATP activity and interindividual variability in clazosentan pharmacokinetics, and to investigate the association between pharmacokinetic variability and fluid retention-related adverse events.
Basic objectives2 - Pharmacokinetics
Eligibility:
Age-lower limit - ...